Literature DB >> 27099594

Hyponatremia and Hepatorenal Syndrome.

Arpan Mohanty1, Guadalupe Garcia-Tsao1.   

Abstract

Hyponatremia and hepatorenal syndrome are severe complications in patients with cirrhosis and ascites resulting from circulatory abnormalities (splanchnic and systemic vasodilatation) that develop with portal hypertension. Both conditions are associated with an increased risk of death. Hyponatremia and renal failure may develop in patients with cirrhosis due to causes other than portal hypertension. Making an accurate differential diagnosis is important both therapeutically and prognostically. In this article, we discuss the pathophysiology, diagnosis, differential diagnosis, and management of hyponatremia and hepatorenal syndrome in patients with cirrhosis.

Entities:  

Keywords:  Hyponatremia; ascites; cirrhosis; hepatorenal syndrome

Year:  2015        PMID: 27099594      PMCID: PMC4836593     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  73 in total

Review 1.  EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.

Authors: 
Journal:  J Hepatol       Date:  2010-06-01       Impact factor: 25.083

2.  New consensus definition of acute kidney injury accurately predicts 30-day mortality in patients with cirrhosis and infection.

Authors:  Florence Wong; Jacqueline G O'Leary; K Rajender Reddy; Heather Patton; Patrick S Kamath; Michael B Fallon; Guadalupe Garcia-Tsao; Ram M Subramanian; Raza Malik; Benedict Maliakkal; Leroy R Thacker; Jasmohan S Bajaj
Journal:  Gastroenterology       Date:  2013-08-30       Impact factor: 22.682

3.  Intravenous albumin infusion is an effective therapy for hyponatraemia in cirrhotic patients with ascites.

Authors:  P A McCormick; P Mistry; G Kaye; A K Burroughs; N McIntyre
Journal:  Gut       Date:  1990-02       Impact factor: 23.059

4.  Factors related to quality of life in patients with cirrhosis and ascites: relevance of serum sodium concentration and leg edema.

Authors:  Elsa Solà; Hugh Watson; Isabel Graupera; Fanny Turón; Rogelio Barreto; Ezequiel Rodríguez; Marco Pavesi; Vicente Arroyo; Mónica Guevara; Pere Ginès
Journal:  J Hepatol       Date:  2012-07-20       Impact factor: 25.083

5.  Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation.

Authors:  Satheesh Nair; Sumita Verma; Paul J Thuluvath
Journal:  Hepatology       Date:  2002-05       Impact factor: 17.425

6.  The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites.

Authors:  Georgios Kalambokis; Michalis Economou; Andreas Fotopoulos; Jihad Al Bokharhii; Christos Pappas; Afroditi Katsaraki; Epameinondas V Tsianos
Journal:  Am J Gastroenterol       Date:  2005-04       Impact factor: 10.864

7.  Acute kidney injury in decompensated cirrhosis.

Authors:  Cynthia D Tsien; Rania Rabie; Florence Wong
Journal:  Gut       Date:  2012-05-25       Impact factor: 23.059

8.  Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium.

Authors:  Z K Wszolek; R D McComb; R F Pfeiffer; R E Steg; R P Wood; B W Shaw; R S Markin
Journal:  Transplantation       Date:  1989-12       Impact factor: 4.939

9.  Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation.

Authors:  Maria-Carlota Londoño; Mónica Guevara; Antoni Rimola; Miquel Navasa; Pilar Taurà; Antoni Mas; Juan-Carlos García-Valdecasas; Vicente Arroyo; Pere Ginès
Journal:  Gastroenterology       Date:  2006-04       Impact factor: 22.682

10.  Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury.

Authors:  Ravindra L Mehta; John A Kellum; Sudhir V Shah; Bruce A Molitoris; Claudio Ronco; David G Warnock; Adeera Levin
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

View more
  5 in total

1.  The proportion of Model for End-stage Liver Disease Sodium score attributable to creatinine independently predicts post-transplant survival and renal complications.

Authors:  Therese Bittermann; Rebecca A Hubbard; James D Lewis; David S Goldberg
Journal:  Clin Transplant       Date:  2020-02-20       Impact factor: 2.863

2.  Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis.

Authors:  Rosa G Simonetti; Giovanni Perricone; Dimitrinka Nikolova; Goran Bjelakovic; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2019-06-28

3.  Fractional excretion of sodium in hepatorenal syndrome: Clinical and pathological correlation.

Authors:  Ali A Alsaad; Hani M Wadei
Journal:  World J Hepatol       Date:  2016-12-08

4.  Predictors of Development of Hepatorenal Syndrome in Hospitalized Cirrhotic Patients with Acute Kidney Injury.

Authors:  Roula Sasso; Ahmad Abou Yassine; Liliane Deeb
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

5.  Child-Turcotte-Pugh Score, MELD Score and MELD-Na Score as Predictors of Short-Term Mortality among Patients with End-Stage Liver Disease in Northern India.

Authors:  Gagandeep Acharya; Rajeev Mohan Kaushik; Rohit Gupta; Reshma Kaushik
Journal:  Inflamm Intest Dis       Date:  2019-11-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.